Plasma Cell Myeloma
📧 Sign up to get email alerts when something new happens for Plasma Cell Myeloma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: A Vaccine (VSV-hIFNβ-NIS) With or Without Cyclophosphamide and Combinations of Ipilimumab, Nivolumab, and Cemiplimab in Treating Relapsed or Refractory Multiple Myeloma, Acute Myeloid Leukemia or Lymphoma [Phase 1]
A Phase 1 clinical trial evaluating the VSV-hIFNβ-NIS vaccine with or without cyclophosphamide and in combination with ipilimumab, nivolumab…
-
CLINICAL_TRIALS other · 2025-11-10Clinical Trial Update: Neurocognitive Outcomes After Whole Brain Radiation Therapy for Hematologic Malignancies
This clinical trial is evaluating neurocognitive outcomes after whole brain radiation therapy in patients with CNS lymphoma and other hemato…
-
CLINICAL_TRIALS trial_result · 2025-05-09Clinical Trial Update: Umbilical Cord Blood-Derived Natural Killer Cells, Elotuzumab, Lenalidomide, and High Dose Melphalan, Followed by Stem Cell Transplant in Treating Patients With Multiple Myeloma [Phase 2]
Phase 2 trial evaluating cord blood-derived natural killer cells in combination with elotuzumab, lenalidomide, high-dose melphalan, and stem…
-
CLINICAL_TRIALS trial_result · 2025-03-20Clinical Trial Update: Reduced Intensity Chemotherapy and Radiation Therapy Before Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies [Phase 2]
This Phase 2 trial investigates reduced-intensity chemotherapy and radiation therapy before donor stem cell transplantation for various hema…
-
CLINICAL_TRIALS withdrawal · 2024-07-03Clinical Trial Update: Pembrolizumab as Salvage Therapy for the Treatment of Multiple Myeloma in Patients Progressing on CAR-T Cell Therapy [Phase 2]
A Phase 2 trial evaluating pembrolizumab as salvage therapy for plasma cell myeloma patients progressing after CAR-T therapy has been withdr…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-04-16Clinical Trial Update: Chaplain-Delivered Compassion Meditation to Improve Quality of Life in Patients Receiving a Stem Cell Transplant [NA]
A completed clinical trial evaluating chaplain-delivered compassion meditation to improve quality of life in patients undergoing stem cell t…
-
CLINICAL_TRIALS trial_result · 2024-03-12Clinical Trial Update: Enhancing Anti--Tetanus Vaccine Response After Autologous Stem Cell Transplantation [Phase 2]
Phase 2 trial update assessing enhancement of anti-tetanus vaccine response after autologous stem cell transplantation in plasma cell myelom…
-
CLINICAL_TRIALS trial_result · 2024-01-02Clinical Trial Update: Xisomab 3G3 for the Prevention of Catheter-Associated Thrombosis in Patients With Cancer Receiving Chemotherapy [Phase 2]
Phase 2 trial of Xisomab 3G3 for preventing catheter-associated thrombosis in cancer patients undergoing chemotherapy was terminated; result…
-
CLINICAL_TRIALS trial_result · 2023-06-09Clinical Trial Update: High Dose Cyclophosphamide, Tacrolimus, and Mycophenolate Mofetil in Preventing Graft Versus Host Disease in Patients With Hematological Malignancies Undergoing Myeloablative or Reduced Intensity Donor Stem Cell Transplant [Phase 2]
Phase 2 clinical trial evaluating high-dose cyclophosphamide, tacrolimus, and mycophenolate mofetil to prevent graft-versus-host disease in …
-
CLINICAL_TRIALS trial_result · 2023-03-28Clinical Trial Update: Desipramine Hydrochloride and Filgrastim For Stem Cell Mobilization in Patients With Multiple Myeloma Undergoing Stem Cell Transplant [NA]
Clinical trial on desipramine hydrochloride and filgrastim for stem cell mobilization in multiple myeloma patients undergoing stem cell tran…
-
CLINICAL_TRIALS trial_result · 2022-11-14Clinical Trial Update: Pembrolizumab, Ixazomib Citrate, and Dexamethasone in Treating Patients With Relapsed Multiple Myeloma [Phase 2]
A Phase 2 trial evaluating pembrolizumab in combination with ixazomib citrate and dexamethasone for relapsed multiple myeloma has completed …
-
CLINICAL_TRIALS trial_result · 2022-05-23Clinical Trial Update: Pomalidomide, Ixazomib Citrate, and Dexamethasone in Treating Patients With Previously Treated Multiple Myeloma or Plasma Cell Leukemia [Phase 2]
Phase 2 trial evaluating pomalidomide, ixazomib, and dexamethasone in patients with previously treated multiple myeloma or plasma cell leuke…
-
CLINICAL_TRIALS trial_result · 2021-07-30Clinical Trial Update: Pomalidomide, Dexamethasone, and Filgrastim-sndz in Treating Patients With Relapsed or Refractory Multiple Myeloma [Phase 1, Phase 2]
A combined phase 1/2 trial of pomalidomide, dexamethasone, and filgrastim-sndz in relapsed or refractory multiple myeloma has been terminate…
-
CLINICAL_TRIALS trial_result · 2021-06-29Clinical Trial Update: Testing AZD4547 as a Potential Targeted Treatment in Cancers With FGFR Genetic Changes (MATCH-Subprotocol W) [Phase 2]
Phase 2 MATCH-Subprotocol W trial evaluating AZD4547 for cancers with FGFR genetic alterations has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2021-04-06Clinical Trial Update: Testing Nivolumab as a Potential Targeted Treatment in Cancers With Mismatch Repair Deficiency (MATCH-Subprotocol Z1D) [Phase 2]
Phase 2 trial evaluating nivolumab in cancers with mismatch repair deficiency has completed; results were posted in 2021.
-
CLINICAL_TRIALS trial_result · 2021-01-22Clinical Trial Update: Dalteparin in Preventing DVT in Participants With Cancer [NA]
Clinical trial update for dalteparin in preventing DVT in cancer patients; study completed with results posted.
-
CLINICAL_TRIALS trial_result · 2019-12-16Clinical Trial Update: Vaccine Therapy With or Without Cyclophosphamide in Treating Patients With Recurrent or Refractory Multiple Myeloma [Phase 1, Phase 2]
Phase 1/2 trial evaluating a vaccine therapy with or without cyclophosphamide in patients with recurrent or refractory plasma cell myeloma.
-
CLINICAL_TRIALS trial_result · 2019-11-22Clinical Trial Update: Donor Atorvastatin Treatment in Preventing Severe Acute GVHD After Nonmyeloablative Peripheral Blood Stem Cell Transplant in Patients With Hematological Malignancies [Phase 2]
Phase 2 clinical trial assessing donor atorvastatin to prevent severe acute GVHD after nonmyeloablative peripheral blood stem cell transplan…
-
CLINICAL_TRIALS trial_result · 2019-10-11Clinical Trial Update: Donor Umbilical Cord Blood Transplant in Treating Patients With Hematologic Cancer [Phase 2]
Phase 2 clinical trial update on donor umbilical cord blood transplant for hematologic cancers; status completed with results posted.
-
CLINICAL_TRIALS trial_result · 2019-09-09Clinical Trial Update: Daratumumab in Treating Patients With Multiple Myeloma [Phase 2]
Phase 2 clinical trial update of daratumumab in patients with plasma cell myeloma (Multiple Myeloma) completed with results posted.
-
CLINICAL_TRIALS trial_result · 2019-05-29Clinical Trial Update: Autologous Peripheral Blood Stem Cell Transplant Followed by Donor Bone Marrow Transplant in Treating Patients With High-Risk Hodgkin Lymphoma, Non-Hodgkin Lymphoma, Multiple Myeloma, or Chronic Lymphocytic Leukemia [Phase 2]
Phase 2 clinical trial evaluating autologous peripheral blood stem cell transplant followed by donor bone marrow transplant in high-risk B- …
-
CLINICAL_TRIALS trial_result · 2017-11-06Clinical Trial Update: S0115, High-Dose Melphalan and Autologous Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma or Primary Systemic Amyloidosis [Phase 2]
Phase 2 trial update on high-dose melphalan with autologous stem cell transplantation for multiple myeloma and primary systemic amyloidosis.
-
CLINICAL_TRIALS trial_result · 2017-05-04Clinical Trial Update: Pentostatin and Lymphocyte Infusion in Preventing Graft Rejection in Patients Who Have Undergone Donor Stem Cell Transplant [Phase 2]
Phase 2 clinical trial evaluating pentostatin and lymphocyte infusion to prevent graft rejection after donor stem cell transplantation—compl…
-
CLINICAL_TRIALS trial_result · 2017-03-10Clinical Trial Update: Donor Lymphocyte Infusion in Treating Patients With Persistent, Relapsed, or Progressing Cancer After Donor Hematopoietic Cell Transplant [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating donor lymphocyte infusion for patients with persistent, relapsed, or progressing cancer after donor hema…
-
CLINICAL_TRIALS trial_result · 2014-12-23Clinical Trial Update: Bortezomib and Flavopiridol in Treating Patients With Recurrent or Refractory Indolent B-Cell Neoplasms [Phase 1]
A Phase 1 trial evaluating the combination of bortezomib and flavopiridol in patients with recurrent or refractory indolent B-cell neoplasms…